AYTU BIOPHARMA, INC Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q4 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Aytu Biopharma, Inc annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from Q4 2010 to Q3 2023.
  • Aytu Biopharma, Inc Net Cash Provided by (Used in) Operating Activities for the quarter ending September 30, 2023 was -$211K, a 97.7% increase year-over-year.
  • Aytu Biopharma, Inc annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$1.39M, a 72.9% increase from 2023.
  • Aytu Biopharma, Inc annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$5.13M, a 82.2% increase from 2022.
  • Aytu Biopharma, Inc annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$28.8M, a 11% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$211K +$8.94M +97.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q3 2022 -$9.15M -$5.36M -141% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q3 2021 -$3.79M +$4.19M +52.5% Jul 1, 2021 Sep 30, 2021 10-Q/A 2023-02-21
Q1 2021 $19.7M -$900K -4.37% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-17
Q3 2020 -$7.98M -$5M -167% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q1 2020 $20.6M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q3 2019 -$2.99M -$243K -8.87% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q3 2018 -$2.74M +$1.47M +34.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q3 2017 -$4.22M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q4 2014 -$9.33K -$2.47K Sep 1, 2014 Nov 30, 2014 10-Q 2015-01-12
Q4 2013 -$6.86K* +$2.06K Sep 1, 2013 Nov 30, 2013 10-Q 2015-01-12
Q4 2012 -$8.92K +$2.1K +19% Sep 1, 2012 Nov 30, 2012 10-Q 2014-01-10
Q4 2011 -$11K +$872 +7.34% Sep 1, 2011 Nov 30, 2011 10-Q 2013-01-14
Q4 2010 -$11.9K Sep 1, 2010 Nov 30, 2010 10-Q 2011-12-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.